Related references
Note: Only part of the references are listed.Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma
Hyunsoo Cho et al.
CLINICAL CANCER RESEARCH (2021)
FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma
Austin B. Bigley et al.
BLOOD ADVANCES (2021)
FcγR Binding and ADCC Activity of Human IgG Allotypes
Steven W. de Taeye et al.
FRONTIERS IN IMMUNOLOGY (2020)
Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis
Mohamed Zuhair et al.
REVIEWS IN MEDICAL VIROLOGY (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer
Aura Muntasell et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Phenotypic and Functional Analysis of Human NK Cell Subpopulations According to the Expression of FcεRIγ and NKG2C
Kyung Hwan Kim et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming
Cristina Capuano et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells
Ayako Kurioka et al.
FRONTIERS IN IMMUNOLOGY (2018)
Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells
Estefania Paula Julia et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy
Aura Muntasell et al.
FRONTIERS IN IMMUNOLOGY (2017)
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells
Victor A. Gall et al.
CANCER RESEARCH (2017)
Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets
Aura Muntasell et al.
JOURNAL OF IMMUNOLOGY (2016)
Immune Adaptation to Environmental Influence: The Case of NK Cells and HCMV
Alexander Roelle et al.
TRENDS IN IMMUNOLOGY (2016)
Harnessing NK Cell Memory for Cancer Immunotherapy
Todd A. Fehniger et al.
TRENDS IN IMMUNOLOGY (2016)
Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
Lisa L. Liu et al.
CELL REPORTS (2016)
Natural killer cell memory in infection, inflammation and cancer
Adelheid Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
Heinrich Schlums et al.
IMMUNITY (2015)
Epigenetic Modification and Antibody-Dependent Expansion of Memory-like NK Cells in Human Cytomegalovirus-Infected Individuals
Jaewon Lee et al.
IMMUNITY (2015)
Antibody-Mediated Response of NKG2Cbright NK Cells against Human Cytomegalovirus
Marcel Costa-Garcia et al.
JOURNAL OF IMMUNOLOGY (2015)
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Sandra M. Swain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
Tauno Metsalu et al.
NUCLEIC ACIDS RESEARCH (2015)
Fc-Receptor Interactions Regulate Both Cytotoxic and Immunomodulatory Therapeutic Antibody Effector Functions
David J. DiLillo et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Human Cytomegalovirus Infection Promotes Rapid Maturation of NK Cells Expressing Activating Killer Ig- like Receptor in Patients Transplanted with NKG2C-/- Umbilical Cord Blood
Mariella Della Chiesa et al.
JOURNAL OF IMMUNOLOGY (2014)
Human Cytomegalovirus Drives Epigenetic Imprinting of the IFNG Locus in NKG2Chi Natural Killer Cells
Merlin Luetke-Eversloh et al.
PLOS PATHOGENS (2014)
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
Vivien Beziat et al.
BLOOD (2013)
NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus
Aura Muntasell et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Cutting Edge: Antibody-Dependent Memory-like NK Cells Distinguished by FcRγ Deficiency
Tianxiang Zhang et al.
JOURNAL OF IMMUNOLOGY (2013)
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function
Bree Foley et al.
BLOOD (2012)
IL-2-or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients
Maria P. Roberti et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients
Vivien Beziat et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions
Ilwoong Hwang et al.
INTERNATIONAL IMMUNOLOGY (2012)
Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen
Bree Foley et al.
JOURNAL OF IMMUNOLOGY (2012)
Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction
M. Moraru et al.
TISSUE ANTIGENS (2012)
Expansion of a unique CD57+ NKG2Chi natural killer cell subset during acute human cytomegalovirus infection
Sandra Lopez-Verges et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Natural killer cells: from basic research to treatments
Eric Vivier et al.
FRONTIERS IN IMMUNOLOGY (2011)
The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
SaeGwang Park et al.
CANCER CELL (2010)
HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients
Esther M. de Kruijf et al.
JOURNAL OF IMMUNOLOGY (2010)
Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models
Werner Scheuer et al.
CANCER RESEARCH (2009)
Adaptive immune features of natural killer cells
Joseph C. Sun et al.
NATURE (2009)
Human NK cells can control CMV infection in the absence of T cells
Taco W. Kuijpers et al.
BLOOD (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2
Stefania Varchetta et al.
CANCER RESEARCH (2007)
Imprint of human cytomegalovirus infection on the NK ceH receptor repertoire
M Gumá et al.
BLOOD (2004)
IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells
R Parihar et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Share Paper
